Cargando…

Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú

INTRODUCTION: This study aims to determine differences between the number of underlying medical conditions, depression, and anxiety, when controlling for the covariates of age, sex, and completed education. METHODS: Participants (n = 484) indicated the number of medical conditions present during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Krüger-Malpartida, Hever, Arevalo-Flores, Martin, Anculle-Arauco, Victor, Dancuart-Mendoza, Mauricio, Pedraz-Petrozzi, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135661/
https://www.ncbi.nlm.nih.gov/pubmed/35663409
http://dx.doi.org/10.1016/j.rcp.2022.04.004
_version_ 1784714010607747072
author Krüger-Malpartida, Hever
Arevalo-Flores, Martin
Anculle-Arauco, Victor
Dancuart-Mendoza, Mauricio
Pedraz-Petrozzi, Bruno
author_facet Krüger-Malpartida, Hever
Arevalo-Flores, Martin
Anculle-Arauco, Victor
Dancuart-Mendoza, Mauricio
Pedraz-Petrozzi, Bruno
author_sort Krüger-Malpartida, Hever
collection PubMed
description INTRODUCTION: This study aims to determine differences between the number of underlying medical conditions, depression, and anxiety, when controlling for the covariates of age, sex, and completed education. METHODS: Participants (n = 484) indicated the number of medical conditions present during the survey, also including the PHQ-9 and GAD-7, to assess depression and anxiety, respectively. RESULTS: Differences were found between groups of medical conditions and the combined values of PHQ-9 and GAD-7 after controlling for the covariates mentioned above (F(4,954) = 5.78; Wilks’ Λ=0.95; P< 0.0005). The univariate tests showed differences for PHQ-9 (F(2,478) = 8.70; P< 0.0005) and GAD-7 (F(2,478) = 11.16; P< 0.0005) between the 3 groups. Finally, post-hoc analysis showed differences between participants with one medical condition and with no medical condition (PHQ-9: M(D) = 1.82; 95%CI, 0.25-3.40; GAD-7: M(D) = 1.73; 95%CI, 0.55-2.91), and between participants with more than one medical condition and participants with no medical condition (PHQ-9: M(D) = 3.10; 95%CI, 1.11-5.10; GAD-7: M(D) = 2.46; 95%CI, 0.97-3.95). CONCLUSIONS: Our results suggest that people who had a medical condition during the COVID-19 pandemic were more prone to developing severe symptoms of anxiety and depression.
format Online
Article
Text
id pubmed-9135661
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría.
record_format MEDLINE/PubMed
spelling pubmed-91356612022-05-31 Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú Krüger-Malpartida, Hever Arevalo-Flores, Martin Anculle-Arauco, Victor Dancuart-Mendoza, Mauricio Pedraz-Petrozzi, Bruno Rev Colomb Psiquiatr Artículo Original INTRODUCTION: This study aims to determine differences between the number of underlying medical conditions, depression, and anxiety, when controlling for the covariates of age, sex, and completed education. METHODS: Participants (n = 484) indicated the number of medical conditions present during the survey, also including the PHQ-9 and GAD-7, to assess depression and anxiety, respectively. RESULTS: Differences were found between groups of medical conditions and the combined values of PHQ-9 and GAD-7 after controlling for the covariates mentioned above (F(4,954) = 5.78; Wilks’ Λ=0.95; P< 0.0005). The univariate tests showed differences for PHQ-9 (F(2,478) = 8.70; P< 0.0005) and GAD-7 (F(2,478) = 11.16; P< 0.0005) between the 3 groups. Finally, post-hoc analysis showed differences between participants with one medical condition and with no medical condition (PHQ-9: M(D) = 1.82; 95%CI, 0.25-3.40; GAD-7: M(D) = 1.73; 95%CI, 0.55-2.91), and between participants with more than one medical condition and participants with no medical condition (PHQ-9: M(D) = 3.10; 95%CI, 1.11-5.10; GAD-7: M(D) = 2.46; 95%CI, 0.97-3.95). CONCLUSIONS: Our results suggest that people who had a medical condition during the COVID-19 pandemic were more prone to developing severe symptoms of anxiety and depression. Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría. 2022-05-27 /pmc/articles/PMC9135661/ /pubmed/35663409 http://dx.doi.org/10.1016/j.rcp.2022.04.004 Text en © 2022 Published by Elsevier España, S.L.U. on behalf of Asociación Colombiana de Psiquiatría. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Artículo Original
Krüger-Malpartida, Hever
Arevalo-Flores, Martin
Anculle-Arauco, Victor
Dancuart-Mendoza, Mauricio
Pedraz-Petrozzi, Bruno
Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú
title Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú
title_full Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú
title_fullStr Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú
title_full_unstemmed Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú
title_short Condiciones Médicas, Síntomas de Ansiedad y Depresión Durante la Pandemia por COVID-19 en una Muestra Poblacional de Lima, Perú
title_sort condiciones médicas, síntomas de ansiedad y depresión durante la pandemia por covid-19 en una muestra poblacional de lima, perú
topic Artículo Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135661/
https://www.ncbi.nlm.nih.gov/pubmed/35663409
http://dx.doi.org/10.1016/j.rcp.2022.04.004
work_keys_str_mv AT krugermalpartidahever condicionesmedicassintomasdeansiedadydepresiondurantelapandemiaporcovid19enunamuestrapoblacionaldelimaperu
AT arevalofloresmartin condicionesmedicassintomasdeansiedadydepresiondurantelapandemiaporcovid19enunamuestrapoblacionaldelimaperu
AT ancullearaucovictor condicionesmedicassintomasdeansiedadydepresiondurantelapandemiaporcovid19enunamuestrapoblacionaldelimaperu
AT dancuartmendozamauricio condicionesmedicassintomasdeansiedadydepresiondurantelapandemiaporcovid19enunamuestrapoblacionaldelimaperu
AT pedrazpetrozzibruno condicionesmedicassintomasdeansiedadydepresiondurantelapandemiaporcovid19enunamuestrapoblacionaldelimaperu